The effects of basal insulin peglispro vs. insulin glargine on lipoprotein particles by NMR and liver fat content by MRI in patients with diabetes

MLA

Trevor J. Orchard, et al. “The Effects of Basal Insulin Peglispro vs. Insulin Glargine on Lipoprotein Particles by NMR and Liver Fat Content by MRI in Patients with Diabetes.” Cardiovascular Diabetology, vol. 16, no. 1, June 2017, pp. 1–15. EBSCOhost, https://doi.org/10.1186/s12933-017-0555-1.

APA

Trevor J. Orchard, Bertrand Cariou, Margery A. Connelly, James D. Otvos, Shuyu Zhang, Caryl J. Antalis, Tibor Ivanyi, & Byron J. Hoogwerf. (2017). The effects of basal insulin peglispro vs. insulin glargine on lipoprotein particles by NMR and liver fat content by MRI in patients with diabetes. Cardiovascular Diabetology, 16(1), 1–15. https://doi.org/10.1186/s12933-017-0555-1

Chicago

Trevor J. Orchard, Bertrand Cariou, Margery A. Connelly, James D. Otvos, Shuyu Zhang, Caryl J. Antalis, Tibor Ivanyi, and Byron J. Hoogwerf. 2017. “The Effects of Basal Insulin Peglispro vs. Insulin Glargine on Lipoprotein Particles by NMR and Liver Fat Content by MRI in Patients with Diabetes.” Cardiovascular Diabetology 16 (1): 1–15. doi:10.1186/s12933-017-0555-1.